Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.7853
-0.0073 (-0.92%)
Oct 6, 2026, 9:27 AM EDT - Market open
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $12.99 million as of October 6, 2026. Its market cap has decreased by -71.87% in one year.
Market Cap
12.99M
Enterprise Value
19.77M
1-Year Change
-71.87%
Ranking
Category
Stock Price
$0.79
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $12.99M, a decrease of -85.35%. That is a compound annual growth rate of -30.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 12.99M | -8.15% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 14.59M |
| AEON Biopharma | 13.92M |
| IN8bio | 13.80M |
| Niki BioSolutions | 13.52M |
| Vyome Holdings | 13.41M |
| Passage Bio | 13.26M |
| Lisata Therapeutics | 13.25M |
| Daré Bioscience | 12.89M |